78
Participants
Start Date
October 21, 2022
Primary Completion Date
February 1, 2026
Study Completion Date
November 1, 2026
Pembrolizumab
Intravenous infusion
Olaparib
Pill taken by mouth
Temozolomide
Pill taken by mouth
RECRUITING
Memorial Sloan Kettering Cancer Center, New York
RECRUITING
Massachusetts General Hospital, Boston
RECRUITING
Beth Israel Deaconess Medical Center, Boston
RECRUITING
Dana-Farber Cancer Institute, Boston
Merck Sharp & Dohme LLC
INDUSTRY
L. Nicolas Gonzalez Castro, MD, PhD
OTHER